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Abstract
Background: Branchiomotor neurons comprise an important class of cranial motor neurons that innervate the
branchial-arch-derived muscles of the face, jaw and neck. They arise in the ventralmost progenitor domain of the
rhombencephalon characterized by expression of the homeodomain transcription factors Nkx2.2 and Phox2b.
Phox2b in particular plays a key role in the specification of branchiomotor neurons. In its absence, generic
neuronal differentiation is defective in the progenitor domain and no branchiomotor neurons are produced.
Conversely, ectopic expression of Phox2b in spinal regions of the neural tube promotes cell cycle exit and
neuronal differentiation and, at the same time, induces genes and an axonal phenotype characteristic for
branchiomotor neurons. How Phox2b exerts its pleiotropic functions, both as a proneural gene and a neuronal
subtype determinant, has remained unknown.
Results: To gain further insights into the genetic program downstream of Phox2b, we searched for novel
Phox2b-regulated genes by cDNA microarray analysis of facial branchiomotor neuron precursors from
heterozygous and homozygous Phox2b mutant embryos. We selected for functional studies the genes encoding
the axonal growth promoter Gap43, the Wnt antagonist Sfrp1 and the transcriptional regulator Sox13, which
were not previously suspected to play roles downstream of Phox2b and whose expression was affected by Phox2b
misexpression in the spinal cord. While Gap43 did not produce an obvious phenotype when overexpressed in
the neural tube, Sfrp1 induced the interneuron marker Lhx1,5 and Sox13 inhibited neuronal differentiation. We
then tested whether Sfrp1 and Sox13, which are down-regulated by Phox2b in the facial neuron precursors, would
antagonize some aspects of Phox2b activity. Co-expression of Sfrp1 prevented Phox2b from repressing Lhx1,5 and
alleviated the commissural axonal phenotype. When expressed together with Sox13, Phox2b was still able to
promote cell cycle exit and neuronal differentiation, but the cells failed to relocate to the mantle layer and to
extinguish the neural stem cell marker Sox2.
Conclusion: Our results suggest novel roles for Sfrp1 and Sox13 in neuronal subtype specification and generic
neuronal differentiation, respectively, and indicate that down-regulation of Sfrp1 and Sox13 are essential aspects
of the genetic program controlled by Phox2b in cranial motoneurons.
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Background
Branchiomotor (bm) neurons comprise an important
class of cranial motoneurons. They arise in the hindbrain
and rostral cervical spinal cord from the ventralmost pro-
genitor domain characterized by expression of the tran-
scription factors Nkx2.2, Mash1 and Phox2b [1,2].
Targeted mutation in the mouse has shown that their
development crucially depends on Phox2b  whereas the
inactivation of Nkx2.2  or  Mash1  results in only mild
defects of bm development [2-5]. In the absence of
Phox2b, the differentiation of all bm neurons is arrested
at an early stage and their precursors either die by apopto-
sis or switch fate and become serotonergic neurons. Con-
versely, Phox2b induces neurons with bm characteristics
when misexpressed in the neural tube of chicken embryos
[2,6]. Hence, Phox2b appears both necessary and sufficient
for the implementation of a specific cranial motoneuro-
nal phenotype. Loss and gain of function experiments
also show that Phox2b has proneural activity [7] and pro-
motes cell cycle exit and generic neuronal differentiation
[8] (see for review [9]). The development of the facial bm
(fbm) neurons that arise in rhombomere 4 (r4) has been
particularly well studied in the Phox2b knockout embryos.
A number of downstream target genes have been identi-
fied that depend on Phox2b for their expression in fbm
neurons by examining expression of candidate genes and
by a subtractive screening approach. They include generic
markers for young post-mitotic neurons (Tubb3, Nfl, Ebf2,
Math3) and genes more specifically associated with bm
neuron differentiation (Phox2a,  Islet1,  Rgs4,  Tbx20)
([4,10] and unpublished results).
Despite this wealth of information, only part of the
genetic program that depends on Phox2b in fbm neurons
has been identified. Indeed, the subtractive screening
approach proved far from exhaustive since most previ-
ously identified downstream genes were not detected and
none were found to be up-regulated in the mutants. Here
we have used microarrays to compare the patterns of gene
expression in fbm precursors from homozygous
(Phox2bLacZ/LacZ) mutants, in which fbm differentiation is
arrested, with that of heterozygous Phox2b (Phox2bLacZ/+)
embryos, in which fbm neurons are phenotypically nor-
mal. In addition to genes already identified in previous
work, a number of new candidates turned up in the
screen, among which many were up-regulated in the
mutants and might thus be repressed by Phox2b. Most of
the down-regulated genes were panneuronally expressed
in young post-mitotic neurons. They were thus expected
to pop up in the screen, since fewer post-mitotic neurons
are produced in the mutants, and were not analyzed fur-
ther. We selected a few other genes for further study by
gain of function experiments in chicken embryos: Gap43,
whose expression, although panneuronal, was strikingly
enhanced in post-mitotic fbm precursors; and two that
were up-regulated in the mutants, Sfrp1 and Sox13. Over-
expression of Sox13, whose function in neural develop-
ment has not been studied so far, inhibited neuronal
differentiation and the relocation to the mantle layer
(ML) caused by Phox2b misexpression in the embryonic
spinal cord, while that of Sfrp1 prevented the repression of
the interneuronal marker Lhx1,5.
Results
Identification of genes regulated by Phox2b in facial 
branchiomotor precursors
Phox2b being an important regulator of the development
of bm neurons, we wanted to further investigate its func-
tion in the specification of bm neurons by searching for
novel genes regulated by Phox2b in fbm neuron precur-
sors. We thus chose to compare gene expression in ventral
r4 from heterozygous (Phox2bLacZ/+) and homozygous
(Phox2bLacZ/LacZ) embryonic day 10.5 (E10.5) mutant
embryos. At this stage, fbm differentiation is well under-
way in Phox2b+/+ and Phox2bLacZ/+ animals while no signs
of bm differentiation are seen in the homozygous
mutants [4]. Four pairs of Phox2bLacZ/+ and Phox2bLacZ/LacZ
RNA samples were amplified from microdissected ventral
r4, labeled with Cy3 or Cy5, mixed and hybridized to two
mouse cDNA microarrays, a microarray of the 15 K NIA
probe set representing approximately 12,000 different
genes and a home-made NeuroDev microarray represent-
ing 2,000 genes chosen for their expression in developing
nervous tissue. We adopted as criteria for putative
Phox2b-regulated genes a significance analysis of microar-
ray (SAM) score (see Materials and methods) below -3.5
or above 3.5 for genes up- or down-regulated in the
mutants, respectively, and a false discovery rate of 5%. By
these criteria, 51 genes were found to be down-regulated
and 23 up-regulated in the homozygous mutants (Addi-
tional files 1 and 2). Surprisingly, only three genes
showed a greater than twofold change in expression.
However, out of the 12 genes we selected for validation by
in situ hybridization (ISH), 10 were confirmed as being
clearly differentially expressed, despite fold changes as
low as 1.14 and 1.13 for two of them (see below). Part of
the rather low signal ratios on microarrays may be due to
the fact that the floor plate, which should not be affected
in the mutants, was always included in the material used
for RNA preparation.
Only two of the genes that scored as underexpressed in the
mutants, Tubb3 and Nfl, had been known from previous
work ([4] and unpublished data). We selected six for vali-
dation by ISH, which was done on sections through r4
from E10.5 Phox2bLacZ/+ and Phox2bLacZ/LacZ embryos. The
expression of one of them, Sncg, was not noticeably
affected in the mutants (not shown). The remaining five
fell into two categories. App, coding for the amyloid beta
(A4) precursor protein, Mapk8, also known as Jun N-ter-Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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minal kinase (Jnk1), and Tubb3, the beta3-tubulin  gene
(already documented in previous work) are pan-neuronal
genes expressed in all developing neurons. In the mutants,
their expression was interrupted at the dorsal border of
the normally Phox2b+ territory (Figure 1a–d). The small
number of post-mitotic neurons that are generated in the
homozygous mutants and locate to the ML, some of
which are in the process of acquiring a serotonergic fate
[1], thus do not appear to activate these genes that are oth-
erwise pan-neuronal. Gap43, a major growth cone protein
[11,12], and to a lesser extent Nfl, coding for the neurofil-
ament light chain, differed from the others by the fact
that, although pan-neuronal as well, they were more
strongly expressed in the fbm precursors than in other
young post-mitotic neurons. Their expression was extin-
guished in the mutant territory (Figure 1e–h).
In the absence of Phox2b, less post-mitotic neurons are
generated in ventral r4 and pan-neuronal genes are thus
expected to be found down-regulated in the mutants. We
therefore favored for further analysis up-regulated over
down-regulated genes. We chose six genes among the can-
didates that were overexpressed in the mutants for valida-
tion by ISH. One of them, Fgfr1, did not show changes
noticeable by ISH (not shown). The others revealed three
distinct patterns of changes. In the heterozygotes, Igfbp5
was expressed in only part of the Phox2b+ territory in the
ventricular zone (VZ) and was excluded from the mantle
layer (ML), while in the homozygotes, it showed a patchy
distribution throughout the Phox2b+ VZ and was strongly
expressed in the ML (Figure 2a, b). Igfbp5 is a member of
a family of modulators of insulin-like growth factor (IGF)
activity that may also have IGF-independent functions
[13]. Like in our screen, Igfbp5 has obtained top scores in
other differential screens on neural tissues (see, for
instance, [14,15]), signifying perhaps that their expres-
sion is exceptionally labile. Their role in neural develop-
ment has not been explored. Since Igfbp5 has been found
to colocalize with areas of apoptosis during development
[13], its overexpression may be related to the increased
apoptosis caused by lack of Phox2b activity in ventral r4.
Hes1, best known as an effector of Notch signaling
[16,17], is normally weakly expressed in the floor plate
and more strongly in the dorsalmost part of the Phox2b+
VZ in the E10.5 hindbrain, but it invades most of the nor-
mally Phox2b-expressing VZ in a salt-and-pepper pattern
in the mutants (Figure 2c, d).
We found Sfrp1 and Tcf3 to be normally expressed in and
confined to the VZ, Sfrp1 only in the ventral part of the
basal plate, and Tcf3 throughout the neural tube. In the
mutant territory, their expression extended up to the neu-
ral tube border, thus including the post-mitotic neurons
in the ML (Figure 2e–h). A similar expansion into the
mutant ML has been found in previous work for Dll1 and
Nkx2.2, which are normally confined to the VZ [4]. In
contrast to Tcf3, Sfrp1 appeared also to be up-regulated
throughout the mutant VZ: the signal given by the Sfrp1
probe was stronger outside of the fbm progenitors in
Phox2bLacZ/+  embryos, but the reverse was true in
Phox2bLacZ/LacZ animals. Tcfs are transcription factors that
function in the Wnt signaling pathway [18,19]. Secreted
frizzled-related proteins (Sfrps) also function mainly in
the Wnt pathway as antagonists of Wnt signaling, but
Sfrp1 may also exert a Wnt-independent activity as a stim-
ulator of neurite outgrowth and as a growth cone attract-
ant for retinal axons [20-22].
Expression patterns of a subset of genes down-regulated in  ventral r4 of Phox2bLacZ/LacZ embryos Figure 1
Expression patterns of a subset of genes down-regulated in 
ventral r4 of Phox2bLacZ/LacZ embryos. (a-h) In situ hybridiza-
tions on transverse sections of ventral r4 of Phox2bLacZ/+ (a, c, 
e, g) or Phox2bLacZ/LacZ (b, d, f, h) E10.5 mouse embryos. DIG-
labeled riboprobes recognizing App (a, b), Mapk8 (c, d), Nfl 
(e, f) and Gap43 (g, h) mRNA were used. The normally 
Phox2b-expressing region as visualized by anti-beta-galactosi-
dase staining on adjacent sections is delimited by gray bars.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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The Sox genes code for an extended family of SRY-box-
containing transcriptional regulators [23]. Sox13, a mem-
ber of the SoxD group, has been identified as a diabetes
autoantigen expressed in pancreatic beta-cells [24] and
recently as a positive regulator of gamma-delta T cells
[25]. We found Sox13 to be expressed throughout most of
the VZ, but almost absent in fbm progenitors. In the
Phox2b mutants, its expression in the normally Phox2b+ VZ
becomes as strong as elsewhere in the VZ (Figure 2i–l). We
then asked whether Sox13 would also be excluded from
the trigeminal bm progenitors in r2 that also express and
depend on Phox2b. In ventral r2, Phox2b is expressed in the
VZ and bm neuron production is underway at E9.5. One
day later, bm neuron production has ceased and Phox2 is
down-regulated in the VZ [7]. At E9.5, strong Sox13
expression in the VZ was interrupted at the border of the
Phox2b+ territory, similar to what has been observed for
the E10.5 fbm progenitors. At E10.5, when Phox2b expres-
sion was about to disappear in the VZ, Sox13  became
clearly detectable in the ventralmost progenitor domain
(Figure 3a–d). Cessation of Phox2b  expression and bm
neuron production in ventral r2 is accompanied by a fate
switch of the progenitors, which now produce serotoner-
gic neurons. Their production depends on Mash1 activity,
in the absence of which serotonergic neurons are not pro-
duced [7]. We thus asked whether the expansion of Sox13
expression would take place in Mash1 mutants. Indeed, in
Mash1-/- embryos, Sox13  expression did not invade the
ventral progenitor domain, although Phox2b expression
has ceased in the VZ (Figure 3e, f).
In Hamburger and Hamilton stage 18 (HH18) chicken
hindbrain, we also found Sox13 expression very weak or
absent in the Phox2b+ domain that gives rise to bm/vis-
ceromotor neurons, while it extended into the ventral pro-
genitor domain at HH24, when Phox2b has disappeared
there. At this stage, a distinct Phox2b+ progenitor domain
has formed in the basal alar plate. Strikingly, Sox13
expression in the VZ was interrupted at this location (Fig-
ure 3g–j). Together, these results suggest that Phox2b
represses Sox13 expression in the hindbrain VZ. The effect
may be indirect since Sox13 continues to be down-regu-
lated in the progenitors when Mash1 is absent.
Gap43, Sfrp1 and Sox13 are regulated by Phox2b 
misexpression in the spinal cord
We then selected Gap43, Sfrp1 and Sox13 for gain of func-
tion experiments in the chicken embryo spinal cord to ask
whether they were regulated by ectopically expressed
Phox2b. We chose Gap43  as a panneuronal Phox2b-
dependent gene because it was more strongly expressed in
fbm neurons, Sfrp1 as an example of the VZ genes that
expand into the mutant ML since it was at the same time
up-regulated in the VZ, and Sox13  because  Phox2b
repressed it in bm progenitors.
Expression patterns of a subset of genes up-regulated in ven- tral r4 of Phox2bLacZ/LacZ embryos Figure 2
Expression patterns of a subset of genes up-regulated in ven-
tral r4 of Phox2bLacZ/LacZ embryos. (a-j) In situ hybridizations 
on transverse sections of ventral r4 of Phox2bLacZ/+ (a, c, e, g, 
i) or Phox2bLacZ/LacZ (b, d, f, h, j) E10.5 mouse embryos. DIG-
labeled riboprobes recognizing Igfbp5 (a, b), Hes1 (c, d), Sfrp1 
(e, f), Tcf3 (g, h) and Sox13 (i, j) mRNA were used. (k, l) 
Immunofluorescence with an antibody recognizing Sox13 on 
transverse sections of ventral r4 of Phox2bLacZ/+(k) or 
Phox2bLacZ/LacZ (l) E10.5 mouse embryos.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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We thus examined whether Phox2b electroporated into the
spinal cord of HH12-13 chicken embryos could up-regu-
late Gap43 and down-regulate Sfrp1 and Sox13 expression,
in line with the changes observed in Phox2b homozygous
mutants. Gap43, normally expressed at this stage mainly
in the post-mitotic motoneurons, was weakly up-regu-
lated in the VZ at 24 hours after electroporation (hae). It
was massively induced in the ML at 48 hae (Figure 4a, b).
To exclude the possibility that this was a trivial conse-
quence of the fact that Phox2b triggered neuronal differ-
entiation, we overexpressed Ngn2, which has a similar
propensity to promote neuronal differentiation [6,26].
Ngn2, however, had no effect on Gap43 expression (Figure
4c, d). Sfrp1, normally expressed in a broad band of the
VZ, was drastically down-regulated at 24 hae Not surpris-
ing for a cell-autonomous effect, Sfrp1  expression was
only marginally affected at 48 hae, when the Phox2b-trans-
fected cells had become post-mitotic and had moved to
the ML. Ngn2 transfection did not induce changes in Sfrp1
expression (Figure 4e–h). The situation with regard to
Sox13 was more complex. We found Sox13 expression to
be confined to the VZ. At 24 hae in the Phox2b-transfected
side, areas where Sox13 appeared to be repressed alter-
nated with areas in which Sox13 was up-regulated, reflect-
ing perhaps a highly dynamic expression pattern. Such a
pattern was not seen after electroporation of Ngn2, which
had instead a slight propensity of inducing Sox13 post-
mitotically (Figure 4i–l). These results show that the
changes in Gap43, Sfrp1 and Sox13 expression are not a
simple consequence of the cells becoming prematurely
post-mitotic and suggest that Phox2b does not exert its
effect through a complex cascade of transcriptional events
since the changes are already seen at 24 hae.
GAP43 overexpression does not grossly affect neural tube 
morphology
Misexpression of Phox2b or its paralogue Phox2a in spinal
regions of the neural tube induces neuronal differentia-
tion and a bm neuronal fate and imposes an axonal phe-
notype that shares many features with that of bm neurons.
Many dorsally located Phox2-transfected neurons, instead
of growing commissural axons as they normally do,
project into the periphery through dorsal exit points as
bm neurons do, but also at ectopic sites [2] (Figure 5c, d).
As Gap43 is up-regulated by Phox2b both in fbm precur-
sors and when misexpressed in the spinal cord, we thus
tested whether it would mimic this phenotype and, in par-
ticular, induce axonal growth when overexpressed in the
chicken neural tube. However, after electroporation of
Gap43, the morphology of the neuroepithelium remained
grossly normal. Neither did the cells relocate to the ML
nor were there any signs of aberrant or increased axonal
growth as produced by Phox2b (Figure 5e, f).
Sfrp1 and Sox13 overexpression counteracts some of the 
effects of Phox2b misexpression
Overexpression of Sfrp1  in the chicken embryo spinal
cord also did not produce gross anatomical alterations in
the neural tube detectable by green fluorescent protein
(GFP) labeling (Figure 6a, compare with Figure 5a). Since
Sox13 is down-regulated by Phox2b-expressing cells in the  hindbrain Figure 3
Sox13 is down-regulated by Phox2b-expressing cells in the 
hindbrain. (a-f) In situ hybridizations on transverse sections 
of ventral r2 from wild-type (a-d) or Mash1-/- (e, f) E9.5 (a, b) 
or E10.5 (c-f) mouse embryos with DIG-labeled riboprobes 
recognizing Sox13 (a, c, e) or Phox2b (b, d, f). At E9.5, Sox13 
expression is excluded from the ventral progenitor domain 
expressing Phox2b, but invades the progenitor domain when 
Phox2b expression has disappeared at E10.5 in wild-type 
(arrowhead), but not in Mash1-/- embryos. The Phox2b-
expressing region as visualized in (b, d, f) is delimited by 
white bars. (g-j) In situ hybridizations on transverse sections 
of ventral r4 of HH18 (g, h) or HH24 (i, j) chicken embryos 
with DIG-labeled riboprobes recognizing Sox13 (g, i) or 
Phox2b (h, j). Asterisks mark a lateral Phox2b+ progenitor 
domain, which does not express Sox13.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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Sfrp1 appeared to be repressed by Phox2b in fbm precur-
sors and when misexpressed in the spinal cord, we asked
whether Sfrp1 would counteract some of the effects pro-
duced by Phox2b misexpression. After co-electroporation
of Sfrp1 together with Phox2b, virtually all transfected cells
expressed both GFP from the Sfrp1 expression vector and
Phox2b, showing that co-expression is highly efficient
(Figure 6d). When expressed together with Phox2b in this
way, Sfrp1 did not prevent Phox2b from either driving neu-
ronal differentiation and relocation to the ML or promot-
ing ectopic neural tube exit of axons (Figure 6c, d; data not
shown).
However, forced expression of the Phox2 genes [2] (Fig-
ures 5c and 6b) suppresses the growth of commissural
axons, while cells co-transfected with Sfrp1 and Phox2b
clearly grew commissural fibers as revealed by GFP stain-
ing in five out of five electroporated embryos (that is, n =
5/5; Figure 6c). To visualize the trajectory of pre-crossing
commissural axons in electroporated embryos, we used
anti-axonin-1 (TAG-1 in mammals) antibodies known to
strongly label commissural fibers [27]. Sfrp1 overexpres-
sion did not change the normal pattern of extension of
commissural axons, which form a conspicuous fascicle
running along the medial border of the motoneuron col-
Regulation of Gap43, Sfrp1 and Sox13 expression by Phox2b in the chicken spinal cord Figure 4
Regulation of Gap43, Sfrp1 and Sox13 expression by Phox2b in the chicken spinal cord. (a-l') Chicken neural tubes electropo-
rated at HH12-13 with pCAGGS::Phox2b-IRES-EGFP (a-b', e-f', i-j') or with pCAGGS::Ngn2 together with pCAGGS::EGFP (c-d', g-h', 
k-l') were analyzed 24 or 48 h after electroporation using DIG-labeled riboprobes recognizing GFP, Gap43, Sfrp1 or Sox13 
mRNA. The asterisk in (i') marks cells in the transfected area where Sox13 was clearly down-regulated by Phox2b; it was rather 
up-regulated in adjacent cells. The asterisk in (l') marks cells in the transfected area where Sox13 was upregulated by Ngn2. 
Each experiment was repeated three times on different embryos with identical results.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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umn (Figure 6g; n = 4/4). As expected, the axonin-1-
expressing fascicle was absent at the transfected side after
Phox2b  electroporation (Figure 6f; n = 9/9). Still, anti-
axonin-1-labeled fibers were observed in the Phox2b-
transfected dorsal spinal cord, but they neither formed a
tight fascicle nor extended beyond the dorsal border of the
motoneuron column. Co-expressing Sfrp1 together with
Phox2b partially, but not completely, restored the axonin-
1-labeled fascicle that extends towards the floor plate (Fig-
ure 6h; n = 6/6).
The commissural axonal phenotype prompted us to ask
whether Sfrp1 may counteract some of the fate changes
affected by Phox2b. Sustained expression of Sfrp1 together
with Phox2b reduced, but did not abrogate, the induction
of Islet1,2 (Figure 6e; n = 3/3), normally seen after trans-
fecting Phox2b alone [2,6]. Phox2b, in addition to induc-
ing bm markers, represses the interneuronal marker
Lhx1,5 [2] (Figure 7a), which is normally expressed by the
interneuron populations dI2, dI4, dI6 and V0 [28,29].
This effect was offset by co-expressing Sfrp1 (Figure 7c; n
= 5/5). Hence, the cells now expressed a mixed pheno-
type, which is not normally encountered: Phox2b+, Islet1,
2+, Lhx1,5+. Sfrp1 increased the number of Lhx1,5-express-
ing cells in the dorsal spinal cord also when expressed
alone, explaining its ability to counteract the down-regu-
lation of Lhx1,5 caused by Phox2b. After Sfrp1 electropora-
tion, the gap in Lhx1,5 expression corresponding to the
dI5 neurons was not observed anymore at the transfected
side (Figure 7b; n = 9/10). A fainter but clearly visible sig-
nal was also seen in the Sfrp1-transfected VZ in cells with
neuroepithelial morphology, whereas it was never
observed in control conditions, suggesting that Lhx1,5 is
induced ectopically in the presence of Sfrp1 (Figure 7b; n
= 9/10). Finally, we examined Pax2, which is expressed by
several Lhx1,5+ populations [28], as a second marker of
spinal interneurons. As expected, misexpression of Phox2b
also down-regulated Pax2 in the transfected cells (Figure
7d; n = 3/3). In contrast to Lhx1,5, however, Pax2 was
down-regulated as well by overexpressing Sfrp1  alone
(Figure 7e; n = 3/3), and consequently, Sfrp1 did not pre-
vent Phox2b from down-regulating Pax2 (Figure 7f; n = 3/
3). Hence, Sfrp1 overexpression affects the phenotype of
the neurons that are generated and thwarts the ability of
Phox2b to induce a bm phenotype.
Sfrp1 (SARP2) has been found to sensitize cells in culture
to pro-apoptotic stimuli, whereas Sfrp2 had the opposite
effect [30] and prevented programmed cell death in the
neural crest [31]. We thus tested whether Sfrp1  might
influence cell death in our overexpression paradigm. In
line with published data [32], we found very few apop-
totic cells in the neural tube at the stages studied (one to
four TUNEL+ cells per section), and their number differed
neither between electroporated and non-electroporated
sides of the neural tube nor among different conditions
(electroporation of Srp1 or Phox2b or of Sfrp1 plus Phox2b)
(not shown).
In the chicken and mouse VZ, cells highly expressing
Sox13 alternate with cells that express it less (Figures 2i, k
and 4i', j'), a pattern that seems to be accentuated by over-
expressing Phox2b (Figure 4i'). Such a pattern suggests that
Sox13 expression in neuroepithelial cells is dynamic, per-
haps in relation to their commitment to a neuronal fate.
VZ expression of Sox13 driven by a strong constitutive pro-
Overexpression of Gap43 does not mimic the effects of  Phox2b on relocation to the mantel layer and axonal growth Figure 5
Overexpression of Gap43 does not mimic the effects of 
Phox2b on relocation to the mantel layer and axonal growth. 
(a-f) Vectors expressing either GFP alone (a, b) or Phox2b 
and GFP (c, d) or Gap43 and GFP (e, f) were electroporated 
into the spinal cord of HH12-13 chicken embryos and GFP 
was visualized by immunohistochemistry 48 hae (a, c, e) or 3 
days after electroporation (dae) (b, d, f). Each experiment 
was repeated three times on different embryos with identical 
results.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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Sfrp1 partially restores a commissural axonal phenotype Figure 6
Sfrp1 partially restores a commissural axonal phenotype. (a-c) Chicken neural tubes electroporated at HH12-13 with 
pCAGGS::Sfrp1-IRES-EGFP (a), pCAGGS::Phox2b-IRES-EGFP (b) or pCAGGS::Sfrp1-IRES-EGFP plus pCAGGS::Phox2b-IRES-EGFP (c) 
were analyzed by anti-GFP immunohistochemistry. Expression of Sfrp1 did not grossly alter the morphology of neuroepithelial 
cells, neither did it prevent Phox2b from promoting relocation to the ML. However, Sfrp1 prevented Phox2b from repressing 
the growth of commissural axons (arrowheads). (d-d") Chicken neural tubes electroporated with pCAGGS::Sfrp1-IRES-EGFP 
and a Phox2b expression vector were analyzed by anti-GFP and anti-Phox2b immunohistochemistry as indicated. Virtually all 
the transfected cells express both GFP and Phox2b. (e-e") Chicken neural tubes electroporated with pCAGGS::Sfrp1-IRES-EGFP 
plus pCAGGS::Phox2b-IRES-EGFP were analyzed by anti-GFP and anti-Islet1,2 immunohistochemistry as indicated. Co-expression 
of Sfrp1 did not prevent Phox2b from inducing Islet1,2 (bracket). (f-h') Chicken neural tubes electroporated with 
pCAGGS::Phox2b-IRES-EGFP (f, f'), pCAGGS::Sfrp1-IRES-EGFP (g, g') or with pCAGGS::Sfrp1-IRES-EGFP plus pCAGGS::Phox2b-IRES-
EGFP (h, h') were analyzed by anti-axonin-1 and anti-GFP immunohistochemistry. In (f, g, h), the anti-axonin-1 staining is shown 
alone, and in (f', g', h') it is merged with the anti-GFP immunofluorescence. The fascicle formed by the commissural fibers en 
route to the floor plate is marked by an asterisk; it is absent after Phox2b transfection and partially restored by co-expressing 
Sfrp1.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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moter should cancel out these changes in expression.
When overexpressed in this way, Sox13 did not disrupt
neural tube structure or grossly alter neuroepithelial cell
morphology. The transfected cells incorporated bromo-
deoxyuridine (BrdU; Figure 8e; n = 3/3) and most
expressed the VZ cell marker Sox2 (Figure 8h; n = 3/3).
However, there were less cells expressing the neuronal
marker NeuN in the transfected area, and none of the
transfected cells co-expressed NeuN (Figure 8b; n = 3/3),
indicating that constitutively high expression of Sox13
inhibits neuronal differentiation.
We next tested the idea that Sox13 overexpression may
antagonize Phox2b in its capacity to drive neuronal differ-
entiation.  Phox2b  misexpressed alone causes the trans-
fected cells to accumulate in the ML and to express NeuN
Changes in Lhx1,5 and Pax2 expression after Sfrp1 transfection Figure 7
Changes in Lhx1,5 and Pax2 expression after Sfrp1 transfection. (a-c') Chicken neural tubes electroporated at HH12-13 with 
pCAGGS::Phox2b-IRES-EGFP (a, a'), pCAGGS::Sfrp1-IRES-EGFP (b, b') or with pCAGGS::Sfrp1-IRES-EGFP plus pCAGGS::Phox2b-IRES-
EGFP (c, c') were analyzed by anti-Lhx1,5 and anti-GFP immunohistochemistry. In (a, b, c), the anti-Lhx1,5 staining is shown 
alone, and in (a', b', c') it is merged with the anti-GFP immunofluorescence. Phox2b represses Lhx1,5 normally expressed in 
interneuron populations dI2, dI4, dI6 and V0 (brackets), while Sfrp1 increases the number of Lhx1,5+ cells (asterisk) and coun-
teracts Phox2b in its capacity of repressing Lhx1,5 (compare (a) and (c)). (d-f') Chicken neural tubes electroporated at HH12-
13 with pCAGGS::Phox2b-IRES-EGFP (d, d'), pCAGGS::Sfrp1-IRES-EGFP (e, e') or with pCAGGS::Sfrp1-IRES-EGFP plus 
pCAGGS::Phox2b-IRES-EGFP (f, f') were analyzed by anti-GFP immunohistochemistry or by ISH with a Pax2 probe as indicated. 
Pax2 is down-regulated in all three conditions.Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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Sox13 overexpression partly antagonizes Phox2b activity Figure 8
Sox13 overexpression partly antagonizes Phox2b activity. (a-m") Chicken neural tubes electroporated at HH 12–13 either 
separately with pCAGGS::Phox2b-IRES-EGFP (a-a", d-d", g-g", j-j") or pCAGGS::Sox13-IRES-EGFP (b-b", e-e", h-h", k-k") or with 
pCAGGS::Phox2b-IRES-EGFP plus pCAGGS::Sox13-IRES-EGFP (c-c", f-f", i-i", l-l", m-m") were analyzed 48 h after electroporation. 
Transverse sections were stained with anti-GFP antibodies in combination with anti-NeuN (a-c"), anti-Sox2 (g-i"), anti-Islet1/2 
(j-l") or anti-Lhx1,5 immunohistochemistry (m-m") or in combination with anti-BrdU antibodies (d-f") after BrdU injection into 
the amniotic cavity 2 h before fixation. Phox2b induces and Sox13 represses NeuN (asterisks in (a', a", b')) in the ML. When co-
expressed with Sox13, Phox2b is still capable of inducing NeuN, which, however, is now also switched on in the VZ (c', c"). 
Cells electroporated with Phox2b are BrdU-negative whether Sox13 was co-transfected (f) or not (d). Cells electroporated 
with Sox13 whether co-transfected with Phox2b (i) or not (h) express Sox2, while cells electroporated with Phox2b alone are 
always Sox2-negative (g). Islet1,2 induction by Phox2b (j) is abolished by co-transfection of Sox13 (l). Repression of Lhx1,5 by 
Phox2b is not prevented by co-expressing Sox13 (m). Co-transfection of Sox13 together with Phox2b inhibits relocation to the 
ML (c, f, i, l, m) implemented by expression of Phox2b alone (a, d, g, j).Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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(Figure 8a), as expected from its propensity to promote
neuronal differentiation and relocation to the ML. When
Sox13  was misexpressed together with Phox2b, many
transfected cells remained in the VZ where they either
retained the morphology of neuroepithelial cells or aggre-
gated near the lumen of the neural tube (Figure 8c, f, l; n
= 3/3). Phox2b was still able to induce NeuN, but now
many cells double-positive for NeuN and GFP were
located in the VZ and had the morphology of neuroepi-
thelial cells. Hence, Sox13, although unable to inhibit
induction of NeuN by Phox2b, appears to prevent the
transfected cells from losing their neuroepithelial mor-
phology and from relocating to the ML. We then investi-
gated further the phenotype of the cells constitutively co-
expressing Phox2b and Sox13. We first established that, in
the presence of Sox13, Phox2b was still able to promote
cell cycle exit as shown by the fact that the transfected cells
did not incorporate BrdU (Figure 8f; n = 3/3). However,
while the neural stem cell marker Sox2 [33] was never
expressed in cells transfected with Phox2b alone, many
doubly transfected cells still expressed Sox2 (Figure 8g, i;
n = 3/3). Finally, we examined Islet1,2 as a marker for the
bm phenotype induced by Phox2b, and Lhx1,5 as a marker
for interneurons. Induction of Islet1,2 was completely
repressed by co-transfection with Sox13 (Figure 8j, l; n = 3/
3). By contrast, Sox13 did not prevent down-regulation of
Lhx1,5 after Phox2b transfection, a result to be expected
since Sox13 overexpression inhibits neuronal differentia-
tion (Figure 8m; n = 3/3).
Discussion
Phox2b plays a key role in the formation of two important
classes of cranial motoneurons, the bm and the closely
related visceromotor neurons. Its role in motoneuronal
differentiation has been studied in most detail during dif-
ferentiation of the fbm neurons. This work has yielded a
few genetic targets whose expression is dependent on
Phox2b in fbm precursors [4,10]. To search for Phox2b-
regulated genes by a more systematic approach, we have
used gene expression profiling of ventral r4, in which the
fbm precursors arise, from heterozygous and homozygous
Phox2b mutant embryos. In this way we have identified a
number of candidates that are either up- or down-regu-
lated in the homozygous mutants. Two of these candi-
dates regulated by Phox2b had been identified in previous
work, but none of the others have been reported before.
We restrict our discussion to those candidates we con-
firmed by ISH as being regulated by Phox2b in ventral r4.
Our analysis did not distinguish between genes that were
under direct control of Phox2b and genes that depended
on Phox2b indirectly, through the action of other tran-
scription factors. However, the genes that we found
induced or repressed in the chicken spinal cord already at
24 hae can be supposed to be proximal targets in the
genetic program induced by Phox2b, and not to be
dependent on a vast network of other factors. So far, only
transcriptional activation by Phox2b has been demon-
strated, but the possibility exists that it may also act as a
repressor, as indicated by the observation that repressor
forms of Phox2b reproduced some of the effects of
Phox2b [6].
Since less post-mitotic neurons are produced in the
mutant territory, it was to be expected that many genes
that are normally expressed in young post-mitotic neu-
rons would be underrepresented in Phox2bLacZ/LacZ
embryos. App, Mapk8, Nfl and Gap43 belong to this cate-
gory. Although post-mitotic cells are produced by
Phox2bLacZ/LacZ progenitors and migrate to the ML, albeit in
reduced numbers, the ML cells failed to express these
genes. The same pattern has been found in previous work
for other post-mitotic markers [4]. Some of the post-
mitotic cells that arise in the mutants then go on to
become serotonergic neurons [1,7]. Apparently, in the
absence of Phox2b and its proneural activity, these cells
will acquire neuronal properties only at later stages.
Gap43 is a case apart since its expression in post-mitotic
neurons was distinctly stronger in fbm precursors than
elsewhere in r4, suggesting that high Gap43 activity may
be required for proper fbm differentiation. Gap43 was also
markedly up-regulated by ectopic Phox2b expression in
the spinal cord, an effect that could not be ascribed to an
increase in generic neuronal differentiation since Ngn2
overexpression was without effect. Gap43 was originally
described as a protein associated with growing axons,
both in development and during regeneration, and is
thought to function as a determinant of axonal growth
competence [11,12,34]. Despite a wealth of in vitro data
describing its growth-promoting properties, its in vivo
function is still ill-defined. When constitutively expressed
in adult mice, GAP43 induced branching of motor nerve
terminals and promoted sprouting of nerves after lesion
[35]. In our study, Gap43 overexpression in the embryonic
neural tube did not produce overt morphological altera-
tions. Hence, its effects might be limited to terminal fields
and situations of regeneration. A number of discrete
developmental defects have been reported in Gap43
mutants, including pathfinding defects of the optic nerve
[36], a reduction in serotonergic innervation of the fore-
brain [37] and a failure to form the anterior commissure
[38]. Such a subtle phenotype for a gene expressed in vir-
tually all young neurons may be due to redundancy with
the CAP23 gene [39].
Among the genes found to be up-regulated in mutant ven-
tral r4, Hes1, at the stage studied, was expressed only in the
dorsalmost part of the Phox2b+ VZ in wild-type or hetero-
zygous animals. In Phox2bLacZ/LacZ embryos, its expression
invaded most of the normally Phox2b+  domain. TheNeural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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basic-helix-loop-helix transcription factor of the hairy and
enhancer of split family, Hes1 is best known as an effector
of Notch signaling and, together with its paralogues Hes3
and Hes5, plays a crucial role in maintaining the progen-
itor state of neuroepithelial cells [16,17]. Since Phox2b
drives neural progenitors to exit the cell cycle and to dif-
ferentiate, it is perhaps not surprising that it shuts off a
negative regulator of neural differentiation. This scheme,
however, is complicated by the observation that its para-
logue  Hes5  has been found to be down-regulated in
Phox2bLacZ/LacZ embryos [8]. It appears that the lack of
proneural activity in Phox2b mutants and the consecutive
down-regulation of the Notch ligand Dll1 in the VZ affect
differently the two paralogous genes. The Lef/Tcf proteins
are transcription factors that play pivotal roles in Wnt sig-
naling, functioning mainly as repressors in the absence
and as obligatory co-activators of beta-catenin in the pres-
ence of Wnt ligands [19]. Tcf3 has remained the most
enigmatic member of the family. Loss of Tcf3 results in
early gastrulation defects and perhaps as a consequence to
broad defects in neural tube patterning [40]. Tcf3 has been
said to become undetectable in the mouse embryo from
E10.5 onward [18], but we found it strongly expressed in
E10.5 r4 throughout the VZ. Normally excluded from the
ML, its expression domain invaded the ML in the mutant
territory. This has been observed in previous work also for
Nkx2.2 and Dll1 [41]. Apparently, the post-mitotic cells
that accumulate in the mutant ML are not only unable to
express generic neuronal markers but also do not switch
off genes whose expression is normally confined to the
VZ.
Sfrp1 shared with Tcf3 the tendency to be expressed in the
mutant ML, from which it was normally excluded. How-
ever, the expression pattern of Sfrp1 in r4 was much more
circumscribed than that of Tcf3. It was only expressed in
ventral r4, including the Phox2b+ progenitor domain and
extending up to the middle of the basal plate. In
Phox2bLacZ/+ embryos, its expression was stronger dorsal to
the  Phox2b+  progenitors, but the reverse was true in
Phox2bLacZ/LacZ embryos. In the embryonic chicken spinal
cord, we found Sfrp1 to be strongly expressed in the VZ of
the dorsal basal plate, in line with previous results [42],
and to be massively repressed by Phox2b. Sfrp1 overexpres-
sion in the chicken spinal cord up-regulated the interneu-
ron marker Lhx1,5. When co-expressed with Sfrp1, Phox2b
was still capable of inducing Islet1,2, but became unable
to repress expression of Lhx1,5. Hence, co-expression of
Phox2b and Sfrp1 results in a mixed phenotype that is not
normally encountered in the spinal cord, as also indicated
by the observation that Sfrp1 partially restored the ability
of  Phox2b-transfected neurons to grow commissural
axons. However, expression of Pax2, another interneuro-
nal marker that was down-regulated by Phox2b, was
already reduced by expression of Sfrp1 alone and contin-
ued to be down-regulated when Sfrp1 was co-expressed
with Phox2b.
The Sfrps have been mostly described as secreted inhibi-
tors of Wnt signaling, but there is evidence that they are
able to promote rather than to inhibit Wnt signaling in
some contexts and that they can act through Wnt-inde-
pendent mechanisms [20-22]. In the Wnt1-/-;  Wnt3a-/-
embryonic spinal cord, the dI4 (Lhx1,5+; Pax2+) subclass
of interneurons has been found to be expanded at the
expense of the dI1 and dI2 interneuron populations [43].
In line with these results, we found that Sfrp1 increased
the population of Lhx1,5-expressing cells. Sfrp1, however,
down-regulated Pax2, suggesting that the effect of Sfrp1
overexpression cannot be explained solely by inhibition
of Wnt signaling. Gain of function experiments in the
chicken retina have shown that Sfrp1 promotes neuronal
differentiation and the generation of retinal ganglion cells
and cones at the expense of other cell types by a mecha-
nism that does not involve inhibition of Wnt signaling
[44]. In our study, Sfrp1 overexpression in the spinal cord
did not cause an obvious increase in generic neuronal dif-
ferentiation. Still, our results suggest that Sfrp1 plays a
role in neuronal subtype specification as has been
observed in the retina.
Transcription factors of the B-, C- and E-group Sox pro-
teins have been found to play key roles during early neural
development [33,45-47]. By contrast, much less is known
about the expression of the D-group Sox proteins in neu-
ral tissues and virtually nothing is known about their
function during central nervous system development. In
our screen, the D-group Sox13 gene was the only Sox gene
that scored as a Phox2b-regulated gene. A previous study
reported Sox13 to be expressed mainly by differentiating
neurons in the ML [48]. At the slightly earlier stages and
more caudal regions studied here, we found, by both ISH
and antibody staining, Sox13 to be expressed throughout
and confined to the VZ in both the mouse and chicken
nervous systems. We found Sox13 to be expressed in the
VZ in a salt-and-pepper pattern, patches of high signal
intensity alternating with cells expressing lower levels,
suggesting a highly dynamic expression pattern perhaps in
relation to the commitment to differentiation. VZ cells
that expressed constitutively high levels of Sox13  after
transfection were proliferating as indicated by BrdU incor-
poration and many expressed the neural cell stem marker
Sox2, but none the neuronal marker NeuN, whose expres-
sion in the ML was inhibited. These results may be inter-
preted to mean that the cells normally expressing lower
levels were those destined to become neurons. In E10.5
ventral r4, Sox13 mRNA and protein expression, which
was strong in more dorsal regions, was much weaker in
the fbm progenitor domain, but invaded the normally
Phoxb+ region in the mutants. While Phox2b expression inNeural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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the VZ and motor neuron production is prolonged in ven-
tral r4, peak motor neuron production in r2 occurs at E9.5
and ceases around E10.5 together with Phox2b expression
in the VZ, where the progenitors switch to the production
of serotonergic neurons [1]. Consequently, in E9.5 ventral
r2, Sox13 expression was absent from ventral progenitors,
but became detectable there one day later. At this stage,
the basic-helix-loop-helix factor Mash1 has been found to
be required in this domain as both the sole provider of
proneural activity and a determinant of the serotonergic
phenotype [7]. As shown here, Sox13 expression did not
expand into the ventral progenitor domain when Mash1
was absent, although Phox2b expression had ceased. One
possibility is that Sox13 expression requires activation of
the Notch pathway by its ligands, whose expression
depends on proneural activity provided by Mash1, but
more work is required to ascertain this. The idea that
Sox13 may function as a Notch effector is also supported
by the observation that its overexpression inhibits neuro-
genesis.
In contrast to what might have been expected from the
pronounced down-regulation of Sox13 in Phox2b-express-
ing progenitors, Phox2b misexpression in spinal regions of
the chicken neural tube did not result in downright
repression, but areas of down-regulation alternated with
regions with enhanced expression. Again, one reason may
be that Sox13  expression depends on Notch activity,
which may be repressed by Phox2b but enhanced in neigh-
boring cells by the propensity of Phox2b to induce the
Notch ligand Dll1 [8]. Constitutively high expression of
Sox13, however, counteracted Phox2b  activity in our
ectopic expression paradigm. A major effect was to block
the relocation of the transfected cells to the ML. In the
presence of forced expression of Sox13, Phox2b was still
able to promote cell cycle exit and neuronal differentia-
tion, but now the Phox2b+, NeuN+ and BrdU- cells nor-
mally located in the ML accumulated in the VZ. Many of
the doubly transfected cells expressed Sox2, which was
totally absent from cells transfected with Phox2b alone,
and Islet1,2 induction by Phox2b was inhibited in them.
Hence, Sox13 appears to counteract the capacity of Phox2b
to silence Sox2 expression and to induce a bm phenotype.
However, blocking migration to the ML may still be the
primary effect, since persistent Sox2 expression and inhi-
bition of Islet1,2 induction may be consequences of the
former. So far, the only in vivo function of Sox13 that has
been reported is the promotion of, and a requirement for,
proper development of the gamma/delta T cell lineage
[25]. This has been attributed to the inhibition of Wnt sig-
naling by direct interaction with the Wnt effector TCF1.
Given that this also holds true for Sox13 function in the
nervous system, it is interesting that two inhibitors of Wnt
signaling, Sfrp1 and Sox13, appeared in our screen. How-
ever, Sfrp1 and Sox13 act on different processes: Sox13
inhibits generic neuronal differentiation while Sfrp1
affects cell type specification. Repression of both may thus
be a prerequisite for proper development of bm neurons.
Sox13 knockout mice die at birth from unknown reasons
[25], and this may well be because of defective neural
development. Our results showing that Sox13  inhibits
neurogenesis and blocks migration to the ML give a first
glance of the possible in vivo functions of Sox13 in neural
development, opening the way for future mechanistic
studies.
Materials and methods
Mice and embryo dissection
Phox2bLacZ/+ mice [49] were intercrossed and the hind-
brains of E10.5 embryos were dissected out and incubated
for 2 minutes at 37°C with 1 μg/μl fluorescein di-(beta-D-
galactopyranoside) (Sigma-Aldrich, Lyon, France). The
left and right beta-galactosidase expressing domains of
ventral r4 with the floorplate in between were excised
under a fluorescent binocular and stored at -20°C in
RNALater solution (Ambion, Austin, TX, USA). The rest of
the embryo was used for genotyping as described by Pat-
tyn et al. [49]. Mash1+/- mice (obtained from François
Guillemot) were intercrossed and the embryos genotyped
as described [50].
RNA extraction and amplification
Four r4 samples of the same genotype (either Phox2bLacZ/+
or  Phox2bLacZ/LacZ) were pooled together and RNA was
extracted and amplified using the RNAqueous-Micro Kit
(Ambion) and the Message Amp aRNA amplification kit
(Ambion) according to the instructions of the manufac-
turer. The quantity and the quality of the amplified RNA
were verified using Agilent RNA 6000 Nano Assay and
Bioanalyzer 2100 (Agilent Technologies, Massy, France).
cDNA microarray hybridization
Microarray hybridization was done using two cDNA col-
lections, the NIA Mouse 15 k clone sets [51] and the Neu-
roDev clone sets (Ecole normale supérieure local
collection), both spotted on Ultra GAPS II slides (Corn-
ing, Avon, France) using a BioRobotics MicroGrid micro-
arrayer (Genomic Solutions, Huntingdon, UK) by the
Transcriptome platform of ENS, Paris. Amplified RNA (2
μg) was retrotranscribed and labeled with dUTP-Cy5 or
dUTP-Cy3 (Amersham, Piscataway, NJ, USA) using Super-
script III Reverse Transcriptase (Invitrogen, Carlsbad, CA,
USA) in the presence of 5 μg of random primers and
appropriate buffer (Invitrogen). RNA was degraded by
alkaline lysis and cDNA was purified using a QIAquick
purification kit (Qiagen, Courtaboeuf, France). CDNA
microarrays were pre-hybridized for 1 h at 42°C in 5 ×
SSC, 0.1% SDS, 1% bovine serum albumin, washed with
distilled water and dried. They were hybridized overnight
at 42°C in 25% formamide, 5 × SSC, 0.1% SDS with Cy5-Neural Development 2008, 3:14 http://www.neuraldevelopment.com/content/3/1/14
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and Cy3-labeled cDNA, washed in 1 × SSC, 0.2% SDS at
42°C, in 0.1 × SSC, 0.2% SDS and two times in 0.1 × SSC
at room temperature and then spin-dried. Four biological
replicas (independent dissections) for each microarray
(15 k and NeuroDev) were done and each of these replicas
was hybridized independently twice by inverting the labe-
ling dyes (dye-swap). A total of 16 hybridizations where
thus performed, 8 using NIA 15 k microarrays and 8 oth-
ers using NeuroDev slides.
Data acquisition and analysis
The hybridized microarrays were scanned using Genepix
4000B (Molecular Devices, Sunnyvale, CA, USA)) and the
resulting image files analyzed by GenePix Pro 5.0 software
(Axon). For each GenePix output file, two filters were
applied, one to clear out spots and another one to discard
saturating spots where the median foreground intensity
was greater than 60,000 in one of the two channels. The
resulting median foreground intensities were normalized,
without background signal subtraction, for dye bias using
a global Lowess correction [52]. An expression matrix for
each type of microarray (eight experiments each) was cre-
ated gathering all normalized ratio data (M values). After
normalization, we applied on each matrix a hierarchical
clustering algorithm [53] using TMeV software [54] to
detect a possible bias introduced by sample heterogeneity.
The cluster obtained showed a clear separation according
to dye-swap between hybridizations indicative of homog-
enous samples. The two matrices obtained were processed
using the GEPAS web server [55] to remove genes with
more than 30% missing values. A KNN impute step was
performed to calculate missing values for the remaining
genes using the 15 nearest neighbor profiles. A further
scaling step was performed by dividing the ratios for each
gene in one experiment by the experimental standard
deviation and multiplying each value by the mean of all
experimental standard deviations. The ratios were dis-
played such that a positive ratio describes a gene whose
expression is higher in Phox2bLacZ/+ than in Phox2bLacZ/LacZ
embryos. SAM [56] was used to search for differentially
expressed genes and to take advantage of our four biolog-
ical replicates to calculate the SAM score equivalent to the
T-statistic value and to estimate the associated false dis-
covery rate. We fixed the false discovery rate at 5% using
the 90th percentile of falsely called genes. We chose in
addition a SAM score above 3.5 or below -3.5 (for genes
down- or up-regulated in the mutants, respectively) as an
arbitrary cut-off since smaller scores increased the number
of genes whose expression changes could not be con-
firmed by ISH.
Expression vectors and electroporation
We used pCAGGS::Phox2b-IRES2-EGFP  [2],
pCAGGS::Gap43-IRES2-EGFP,  pCAGGS::Sox13-IRES2-
EGFP,  pCAGGS::Sfrp1-IRES2-EGFP  or  pCAGGS::IRES2-
EGFP  to express mouse Phox2b, mouse Gap43, human
SFRP1 (the latter two subcloned from IMAGE clones) and
human  Sox13  (subcloned from Ultimate ORF Clone
IOH44934, Invitrogen) together with GFP or GFP alone in
the chicken neural tube driven by a composite chicken
beta actin-CMV promoter. The spinal region of HH12-14
embryonic chick neural tubes were electroporated in ovo
with the appropriate expression vectors (2 mg/ml or 1
mg/ml) essentially as described [8]. Correct expression of
all constructs was verified by ISH with the cognate probes.
After electroporation, embryos were allowed to develop at
38°C for 24–72 h.
Histological methods
Mouse embryos and well-electroporated chicken
embryos, as assessed by GFP fluorescence, were dissected
out, fixed in 4% paraformaldehyde overnight, embedded
in Tissue-Tek® OCT™ (Sakura-Finetek, Zoeterwoude, The
Netherlands) (mouse embryos) or gelatin (chicken
embryos) and analyzed on 12 or 20 μm transverse cryo-
sections, respectively. The methods used for ISH immuno-
histochemistry were as described previously [2,8]. The
following antibodies were used: rabbit anti-axonin-1 [27],
mouse monoclonal anti-BrdU (1/100; Sigma), mouse
monoclonal (Roche, Basel, Switzerland) and rabbit
(Chemicon, Temecula, CA, USA) anti-GFP (1/400),
mouse anti-Islet1,2 (1/100) [57], rabbit anti-Islet1 (1/
500; Abcam, Paris, France), mouse anti-Lhx1,5 (Develop-
mental Studies Hybridoma Bank), mouse anti-NeuN (1/
500), rabbit anti-Sox2 (1/1,000; Abcam), rabbit anti-
Sox13 [48] and adequate fluorescent secondary antibod-
ies. For NeuN and Sox2 staining, sections were pre-treated
with sodium citrate pH 6, 0.05% Tween-20, and for BrdU
staining, sections were pretreated in 2N HCl, 0.5% Triton
X-100 for 20 minutes at room temperature and neutral-
ized. Apoptotic cells were detected using the Apo Tag kit
(Oncor, Gaithersburg, MD, USA)) according to the man-
ufacturer's instructions.
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